Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

IOpus Genetics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
I

Opus Genetics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027
    Sep 9, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
    Sep 2, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Aug 19, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
    Aug 6, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease
    Aug 3, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
    Jul 9, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease
    Jul 6, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
    Jun 26, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
    Jun 16, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts
    Jun 2, 2026Opus Genetics, Inc. (IRD) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$5.16Close · Sep 22, 2026